Invivyd (IVVD) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

IVVD Stock Forecast

Invivyd stock forecast is as follows: an average price target of $9.50 (represents a 2040.12% upside from IVVD’s last price of $0.44) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

IVVD Price Target

The average price target for Invivyd (IVVD) is $9.50 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $9.00. This represents a potential 2040.12% upside from IVVD's last price of $0.44.

IVVD Analyst Ratings

Buy

According to 5 Wall Street analysts, Invivyd's rating consensus is 'Buy'. The analyst rating breakdown for IVVD stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Invivyd Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Apr 05, 2024	Evan Wang	Guggenheim	$9.00	$3.58	151.40%	1927.48%
Mar 26, 2024	Maxwell Skor	Morgan Stanley	$10.00	$3.23	209.60%	2152.76%

The latest Invivyd stock forecast, released on Apr 05, 2024 by Evan Wang from Guggenheim, set a price target of $9.00, which represents a 151.40% increase from the stock price at the time of the forecast ($3.58), and a 1927.48% increase from IVVD last price ($0.44).

Invivyd Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	2
Avg Price Target	-	-	$9.50
Last Closing Price	$0.44	$0.44	$0.44
Upside/Downside	-100.00%	-100.00%	2040.12%

In the current month, the average price target of Invivyd stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Invivyd's last price of $0.44. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 30, 2024	EF Hutton		Buy	Initialise
Aug 28, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 05, 2024	Guggenheim		Buy	Upgrade
Mar 26, 2024	Morgan Stanley		Overweight	Upgrade
Dec 16, 2021	Jefferies	Buy	Buy	Hold

Invivyd's last stock rating was published by EF Hutton on Oct 30, 2024. The company Initialise its IVVD rating from "null" to "Buy".

Invivyd Financial Forecast

Invivyd Revenue Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$327.27M	$314.68M	$314.68M	$302.09M	$277.74M	$267.05M	$267.05M	$256.37M	$137.49M	$132.21M	$132.21M	$126.92M	$51.38M	$46.10M	$41.47M	$36.89M	$39.20M	$27.25M	$5.00M
High Forecast	$395.74M	$380.52M	$380.52M	$365.30M	$335.85M	$322.93M	$322.93M	$310.02M	$166.26M	$159.87M	$159.87M	$153.47M	$62.13M	$55.75M	$50.15M	$49.45M	$42.26M	$32.95M	$6.05M
Low Forecast	$255.32M	$245.50M	$245.50M	$235.68M	$216.68M	$208.34M	$208.34M	$200.01M	$107.27M	$103.14M	$103.14M	$99.02M	$40.09M	$35.97M	$32.35M	$24.34M	$36.29M	$21.26M	$3.90M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Invivyd's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. IVVD's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Invivyd EBITDA Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict IVVD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Invivyd's previous annual EBITDA (undefined) of $NaN.

Invivyd Net Income Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$127.93M	$124.36M	$125.74M	$119.61M	$114.68M	$111.69M	$113.15M	$107.44M	$54.37M	$53.82M	$55.41M	$51.77M	$6.47M	$4.66M	$2.53M	$-3.36M	$-25.81M	$-40.33M	$-44.61M
High Forecast	$162.73M	$158.19M	$159.95M	$152.15M	$145.88M	$142.08M	$143.93M	$136.66M	$69.16M	$68.46M	$70.48M	$65.85M	$8.23M	$5.93M	$3.21M	$-1.12M	$-17.21M	$-28.80M	$-31.86M
Low Forecast	$91.37M	$88.82M	$89.81M	$85.43M	$81.90M	$79.77M	$80.81M	$76.73M	$38.83M	$38.44M	$39.57M	$36.97M	$4.62M	$3.33M	$1.80M	$-5.60M	$-32.85M	$-51.30M	$-56.75M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Invivyd's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IVVD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Invivyd SG&A Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Invivyd's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to IVVD last annual SG&A of $NaN (undefined).

Invivyd EPS Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$1.07	$1.04	$1.05	$1.00	$0.96	$0.93	$0.95	$0.90	$0.46	$0.45	$0.46	$0.43	$0.05	$0.04	$0.02	$-0.03	$-0.22	$-0.34	$-0.37
High Forecast	$1.36	$1.32	$1.34	$1.27	$1.22	$1.19	$1.20	$1.14	$0.58	$0.57	$0.59	$0.55	$0.07	$0.05	$0.03	$-0.01	$-0.14	$-0.24	$-0.27
Low Forecast	$0.76	$0.74	$0.75	$0.71	$0.69	$0.67	$0.68	$0.64	$0.32	$0.32	$0.33	$0.31	$0.04	$0.03	$0.02	$-0.05	$-0.27	$-0.43	$-0.47
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Invivyd's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IVVD previous annual EPS of $NaN (undefined).

Invivyd Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
UBX	Unity Bio	$1.02	$80.00	7743.14%	Buy
IVVD	Invivyd	$0.49	$9.50	1838.78%	Buy
PASG	Passage Bio	$0.67	$6.00	795.52%	Buy
BDTX	Black Diamond Therapeutics	$2.50	$20.00	700.00%	Buy
CCCC	C4 Therapeutics	$4.05	$20.00	393.83%	Buy
ANEB	Anebulo Pharmaceuticals	$1.31	$6.00	358.02%	Buy
RGNX	REGENXBIO	$8.47	$29.75	251.24%	Buy
ERAS	Erasca	$2.63	$6.00	128.14%	Buy
AVIR	Atea Pharmaceuticals	$3.16	$6.88	117.72%	Hold
EWTX	Edgewise Therapeutics	$30.17	$46.25	53.30%	Buy
RXRX	Recursion Pharmaceuticals	$7.12	$9.67	35.81%	Hold
KRON	Kronos Bio	$0.96	$1.00	4.17%	Buy
ABEO	Abeona Therapeutics	$5.88	$6.00	2.04%	Buy

IVVD Forecast FAQ

Is Invivyd a good buy?

Yes, according to 5 Wall Street analysts, Invivyd (IVVD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of IVVD's total ratings.

What is IVVD's price target?

Invivyd (IVVD) average price target is $9.5 with a range of $9 to $10, implying a 2040.12% from its last price of $0.444. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Invivyd stock go up soon?

According to Wall Street analysts' prediction for IVVD stock, the company can go up by 2040.12% (from the last price of $0.444 to the average price target of $9.5), up by 2152.76% based on the highest stock price target, and up by 1927.48% based on the lowest stock price target.

Can Invivyd stock reach $1?

IVVD's average twelve months analyst stock price target of $9.5 supports the claim that Invivyd can reach $1 in the near future.

What are Invivyd's analysts' financial forecasts?

Invivyd's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $1.07B (high $1.29B, low $833.38M), average EBITDA is $0 (high $0, low $0), average net income is $446.96M (high $568.54M, low $319.22M), average SG&A $0 (high $0, low $0), and average EPS is $3.74 (high $4.76, low $2.67). IVVD's analysts financial forecasts for the fiscal year (Dec 2028) are as follows: average revenue is $1.26B (high $1.52B, low $982M), average EBITDA is $0 (high $0, low $0), average net income is $497.65M (high $633.02M, low $355.42M), average SG&A $0 (high $0, low $0), and average EPS is $4.16 (high $5.3, low $2.97).